Industry / Bulgaria
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Sopharma Cleared Of Wrongdoing In Olympic Doping Scandal
June 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Bulgarian drugmaker Sopharma has been absolved from responsibility for traces of a banned substance in a pharmaceutical product, which led to three Bulgarian weightlifters being stripped of medals at the Sydney 2000 Olympic Games. A Sofia court rejected claims by the Bulgarian Olypic Committee and Bulgarian WEighlifting Federation that Sopharma was to blame for the athletes testing positive for banned diuretic furosemide, based on domestic regulations relating to the composition of medicines. The substance, along with several other diuretics, is included on the World Anti-Doping Agency's banned drug list due to its properties as a masking agent for other banned